GTBP vs REGN: Which Stock is Better?
Side-by-side comparison of GT Biopharma Inc and Regeneron Pharmaceuticals Inc in 2026
GTBP
GT Biopharma Inc
—
REGN
Regeneron Pharmaceuticals Inc
$662.73
Key Metrics Comparison
| Metric | GTBP | REGN | Winner |
|---|---|---|---|
| Market Cap | $17.43M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze GTBP
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GTBP or REGN a better investment?
Comparing GTBP and REGN: GT Biopharma Inc has a market cap of $17.43M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GTBP and REGN?
GTBP (GT Biopharma Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GTBP or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GTBP or REGN?
Both GTBP and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: GTBP or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: GTBP or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $17.43M for GTBP.
Should I buy GTBP or REGN in 2026?
Both GTBP and REGN have investment merit. GTBP trades at $N/A while REGN trades at $662.73. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GTBP and REGN stock?
Key differences: Market Cap ($17.43M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy GTBP or REGN in 2026?
The choice between GTBP and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GTBP and REGN?
GTBP (GT Biopharma Inc) has a market cap of $17.43M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.